Simplex Trading’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.79M Sell
46,400
-26,900
-37% -$993K ﹤0.01% 1925
2025
Q4
$2.6M Buy
73,300
+54,100
+282% +$1.52M ﹤0.01% 1766
2025
Q3
$275K Buy
19,200
+9,900
+106% +$117K ﹤0.01% 4581
2025
Q2
$66K Buy
9,300
+8,900
+2,225% +$49.3K ﹤0.01% 5638
2025
Q1
$2K Sell
400
-43,300
-99% -$339K ﹤0.01% 7950
2024
Q4
$340K Sell
43,700
-600
-1% -$5.98K ﹤0.01% 3927
2024
Q3
$478K Sell
44,300
-23,000
-34% -$224K ﹤0.01% 3637
2024
Q2
$567K Buy
67,300
+16,300
+32% +$124K ﹤0.01% 3535
2024
Q1
$342K Buy
51,000
+25,300
+98% +$156K ﹤0.01% 4243
2023
Q4
$151K Buy
25,700
+17,100
+199% +$131K ﹤0.01% 4964
2023
Q3
$83K Buy
8,600
+7,500
+682% +$89K ﹤0.01% 5276
2023
Q2
$13K Buy
1,100
+200
+22% +$2.29K ﹤0.01% 7148
2023
Q1
$9K Buy
900
+200
+29% +$2.56K ﹤0.01% 7603
2022
Q4
$8K Sell
700
-300
-30% -$3.72K ﹤0.01% 7709
2022
Q3
$14K Sell
1,000
-64,400
-98% -$883K ﹤0.01% 7899
2022
Q2
$589K Buy
65,400
+64,900
+12,980% +$443K ﹤0.01% 3249
2022
Q1
$3K Buy
+500
New +$3.48K ﹤0.01% 9672

Other funds holding COGT

Simplex Trading's COGT Position: Q1 2026 in Review

Simplex Trading opened a new position in Cogent Biosciences (COGT) in Q1 2026: 3,153 shares worth $121K. The stake represents ﹤0.01% of the portfolio and ranks #4859 among its holdings. This is a return to the name: Simplex Trading previously reported a position in COGT as recently as Q3 2025.

Simplex Trading first reported a position in COGT in Q4 2021 and has held it in 11 quarters since. The position peaked at $961K in Q3 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Simplex Trading held 3,153 shares of Cogent Biosciences worth $121K as of Q1 2026.
  • Cogent Biosciences was a new Simplex Trading position in Q1 2026.
  • Cogent Biosciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4859 holding.
  • Simplex Trading first reported a position in Cogent Biosciences in Q4 2021 and has held it in 11 quarters since.
  • Simplex Trading's Cogent Biosciences position peaked at $961K in Q3 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.